Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Myriad Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Myriad Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Myriad Genetics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Myriad Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Myriad Genetics Inc, Medical Equipment, Deal Details 13
Asset Purchase 13
Rules-Based Medicine Acquires Intellectual Property Assets From Satoris 13
Venture Financing 14
Myriad Genetics to Raise Funds through Venture Financing 14
AssureRx Health Raises Additional USD15 Million in Series D Financing 15
AssureRx Health Raises USD7 Million in Venture Financing 16
RainDance Technologies Raises US$20 Million In Series E Financing 18
Crescendo Bioscience Raises US$28 Million In Series D Financing 19
Assurex Health Secures USD12.5 Million in Series C Funding Round 21
Assurex Health Secures USD8 Million in Venture Funding Round 22
Crescendo Bioscience Raises US$56 Million In Series C Financing 23
Sividon Diagnostics Secures Venture Financing 24
AssureRx Plans To Raise US$10 Million In Series A Venture Financing 25
Partnerships 26
Myriad Genetics Enters into Licensing Agreement with Institut Curie and INSERM 26
Myriad Genetics Enters into Licensing Agreement With Children’s Medical Center 27
Myriad Genetics Enters into Licensing Agreement with University of Texas 28
Myriad Genetics Enters Into Licensing Agreement For RAD51C Gene 29
Myriad Genetics Enters Into Licensing Agreement With Chronix Biomedical 30
Sividon Diagnostics Enters into Co-Marketing Agreement with Virchow Labs and Ready Ruixin 31
Myriad Genetics Expands Agreement with AstraZeneca 32
Myriad Genetics Enters Into Co-Marketing Agreement With Sividon Diagnostics For EndoPredict Test 33
Myriad Enters Into Research Agreement With Janssen Research & Development 34
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 35
DaVita Enters Into Agreement With Myriad Genetics For Protein Biomarker Discovery 36
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 37
Acquisition 38
Myriad Genetics Acquires Assurex Health for USD348.5 Million 38
Myriad Genetics Acquires Sividon Diagnostics 40
Myriad Genetics Completes Acquisition Of Crescendo Bioscience For US$270 Million 41
Myriad Genetics Acquires Rules-Based Medicine 43
Myriad Genetics Inc – Key Competitors 45
Myriad Genetics Inc – Key Employees 46
Myriad Genetics Inc – Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Recent Developments 49
Financial Announcements 49
Nov 07, 2017: Myriad Genetics Reports Fiscal First-Quarter 2018 Financial Results 49
May 02, 2017: Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results 50
Feb 07, 2017: Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results 52
Nov 01, 2016: Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results 54
Aug 09, 2016: Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial Results 56
May 03, 2016: Myriad Genetics Reports Fiscal Third-Quarter 2016 Financial Results 58
Feb 02, 2016: Myriad Genetics Reports Fiscal Second-Quarter 2016 Financial Results 60
Corporate Communications 62
Sep 29, 2016: Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy 62
Product News 63
Apr 17, 2017: Study Finds Wide Gap in Quality of BRCA1/2 Variant Classification Between Myriad Genetics and A Common Public Database 63
Oct 17, 2016: Myriad Will Present New Data on Its Variant Classification Program at the ASHG Annual Meeting 65
03/18/2016: Myriad Genetics Presented New Data on myChoice HRD at the Society for Gynecologic Oncology Annual Meeting 66
03/18/2016: The Myriad myRisk Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer 67
03/15/2016: Myriad Presents myPlan Lung Cancer test at the 2016 USCAP Annual Meeting 68
03/15/2016: Myriad Presents Second Pivotal Validation Study for Its myPath Melanoma Test 69
03/08/2016: Myriad Advances Proprietary myVision Variant Classification Tools to a Broader Range of Cancer Risk Genes 70
Other Significant Developments 71
Oct 02, 2017: Myriad Genetics Highlights Strong Commitment to Preventing and Fighting Breast Cancer as Part of Breast Cancer Awareness Month 71
Oct 21, 2016: Myriad Genetics Forms Relationship with ION Solutions to Deliver Quality Hereditary Cancer Tests and Services to the Nation’s Largest Network of Community Oncologists 72
Oct 04, 2016: The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing 73
May 18, 2016: Myriad Announces Plans to Launch a Web Portal for Patients that Will Provide Access to Test Results, Tools and Health Information 74
Appendix 75
Methodology 75
About GlobalData 75
Contact Us 75
Disclaimer 75
Myriad Genetics Inc, Medical Equipment, Key Facts, 2017 2
Myriad Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Myriad Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Myriad Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Myriad Genetics Inc, Deals By Market, 2011 to YTD 2017 9
Myriad Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Rules-Based Medicine Acquires Intellectual Property Assets From Satoris 13
Myriad Genetics to Raise Funds through Venture Financing 14
AssureRx Health Raises Additional USD15 Million in Series D Financing 15
AssureRx Health Raises USD7 Million in Venture Financing 16
RainDance Technologies Raises US$20 Million In Series E Financing 18
Crescendo Bioscience Raises US$28 Million In Series D Financing 19
Assurex Health Secures USD12.5 Million in Series C Funding Round 21
Assurex Health Secures USD8 Million in Venture Funding Round 22
Crescendo Bioscience Raises US$56 Million In Series C Financing 23
Sividon Diagnostics Secures Venture Financing 24
AssureRx Plans To Raise US$10 Million In Series A Venture Financing 25
Myriad Genetics Enters into Licensing Agreement with Institut Curie and INSERM 26
Myriad Genetics Enters into Licensing Agreement With Children’s Medical Center 27
Myriad Genetics Enters into Licensing Agreement with University of Texas 28
Myriad Genetics Enters Into Licensing Agreement For RAD51C Gene 29
Myriad Genetics Enters Into Licensing Agreement With Chronix Biomedical 30
Sividon Diagnostics Enters into Co-Marketing Agreement with Virchow Labs and Ready Ruixin 31
Myriad Genetics Expands Agreement with AstraZeneca 32
Myriad Genetics Enters Into Co-Marketing Agreement With Sividon Diagnostics For EndoPredict Test 33
Myriad Enters Into Research Agreement With Janssen Research & Development 34
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 35
DaVita Enters Into Agreement With Myriad Genetics For Protein Biomarker Discovery 36
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 37
Myriad Genetics Acquires Assurex Health for USD348.5 Million 38
Myriad Genetics Acquires Sividon Diagnostics 40
Myriad Genetics Completes Acquisition Of Crescendo Bioscience For US$270 Million 41
Myriad Genetics Acquires Rules-Based Medicine 43
Myriad Genetics Inc, Key Competitors 45
Myriad Genetics Inc, Key Employees 46
Myriad Genetics Inc, Subsidiaries 47